Scleroderma Lung Fibrosis and Biologic Drugs

Rheumatology : Current Research
doi 10.4172/2161-1149.s1-001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Role of Endoglin in Fibrosis and Scleroderma

International Review of Cell and Molecular Biology
BiochemistryCell BiologyMolecular Biology
2012English

Integrin-Modulating Therapy Prevents Fibrosis and Autoimmunity in Mouse Models of Scleroderma

Nature
Multidisciplinary
2013English

Cyclophosphamide Versus Placebo in Scleroderma Lung Disease

New England Journal of Medicine
Medicine
2006English

Hedgehog Dysfunction in Fibrosis: Insights in the Pathogenesis of Scleroderma

Biochemistry & Pharmacology: Open Access
2013English

Amiodarone and Chronic Lung Fibrosis.

Postgraduate Medical Journal
Medicine
1985English

700 Targeting SIRT/CD38/NAD+ Homeostasis to Mitigate Fibrosis in Scleroderma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

MicroRNAs: Their Involvement in Fibrosis Pathogenesis and Use as Diagnostic Biomarkers in Scleroderma

Experimental & Molecular Medicine
2013English

Emerging Drugs for Idiopathic Pulmonary Fibrosis

Expert Opinion on Emerging Drugs
Pharmacology
2011English

Interstitial Lung Disease in Patients With Scleroderma: Treatment With Rituximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy